Stocktoria
NEONC TECHNOLOGIES HOLDINGS, INC. NTHI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-03-26
NEONC TECHNOLOGIES HOLDINGS, INC. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $39,990 | $83,000 |
| R&D expense | $3.6M | $3.0M |
| Operating income | -$58.2M | -$7.1M |
| Interest expense | $2.5M | $2.6M |
| Net income | -$62.1M | -$11.9M |
| EPS (diluted) | $-3.20 | $-0.69 |
| Operating cash flow | -$20.4M | -$4.2M |
| Cash & equivalents | $58,729 | $64,893 |
| Total assets | $2.8M | $3.4M |
| Total liabilities | $20.3M | $8.9M |
| Shareholders' equity | -$17.5M | -$5.5M |
Growth · year-over-year · Revenue CAGR -51.8%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | -51.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.